Update from feeds: https://galaxyproject.org/news/2024-09-16-by-covid-eol/

[galaxy-social-bot]

This PR is created automatically by a feeds bot.
Update since 2024-09-03

Processed:
Viral pathogen data analysis beyond BY-COVID

[github-actions]

👋 Hello! I'm your friendly social media assistant. Below are the previews of this post:
posts/feed_bot/galaxy_europe/2024-09-16-by-covid-eol-group1.md

mastodon-eu-freiburg

📝 New blog post Released!
https://galaxyproject.org/news/2024-09-16-by-covid-eol/

Galaxy Europe and BY-COVID (1/7)

In autumn 2021 the EU-funded BY-COVID project: https://by-covid.org/ was launched to support the response to COVID-19 and our preparedness for future infectious disease outbreaks. Over the past 3 years, the SARS-CoV-2 data analysis efforts of the Galaxy Europe Team have been carried out under the umbrella of BY-COVID with remarkable results.

Among other things, we have:

1. built an automated, scalable SARS-CoV-2 genome surveillance system around Galaxy, which has become a showcase: (2/7)

https://www.infectious-diseases-toolkit.org/showcase/covid19-galaxy project within the Infectious Diseases Toolkit (IDTk): https://www.infectious-diseases-toolkit.org/ developed under BY-COVID, and have used it to analyze nearly 500,000 public SARS-CoV-2 sequencing datasets.
2. collaborated with researchers from the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), South Africa, and international colleagues on a first characterization of the omicron variant of concern when it was first observed in late 2021. Read the original blog (3/7)

post: https://galaxyproject.org/news/2021-11-29-omicron-and-galaxy/ and the resulting publication: https://doi.org/10.1093/molbev/msac061 for more.
3. participated in the NIH-led ACTIV TRACE: https://www.nih.gov/research-training/medical-research-initiatives/activ/tracking-resistance-coronavirus-evolution-trace initiative, under which we helped improve and standardize SARS-CoV-2 genome sequencing pipelines of government agencies and industry. Read the publication: https://doi.org/10.3390/v16030430.
4. extended our analysis support to additional viruses beyond SARS-CoV-2 and have created solutions for influenza: https://usegalaxy.eu/published/page?id=a04ab8d6ecb698fa and pox (4/7)

virus: https://usegalaxy.eu/published/page?id=9172077f52d9d49f sequencing data analysis.
5. offered SARS-CoV-2/One Health/Pathogen data analysis tracks as part of the Global Galaxy Training days in 2022: https://gallantries.github.io/video-library/events/smorgasbord2/tapas.html and 2023: https://gallantries.github.io/video-library/events/smorgasbord3/, and the 2024 Galaxy Training Academy: https://training.galaxyproject.org/training-material/events/galaxy-academy-2024.html in October will feature a dedicated BY-COVID track.

: https://training.galaxyproject.org/training-material/events/galaxy-academy-2024.html

Looking ahead

: https://virology.usegalaxy.eu

BeYond-COVID will reach the end of its funding period in October, but keeping (5/7)

with the project's full name, members of the Galaxy Project and the Galaxy Europe Team will continue their efforts to support high-quality viral pathogen data analysis on the Galaxy platform through the development of tools, workflows, training material and through maintenance of data resources.

To make it easier for you to discover what is available and keep up with future developments, we have set up the subdomain https://virology.usegalaxy.eu earlier this year, which we hope you will find (6/7)

useful. See you there and thanks for using Galaxy!

@[email protected]
#UseGalaxy #GalaxyProject #UniFreiburg #EOSC #EuroScienceGateway (7/7)

matrix-eu-announce

📝 New blog post Released! https://galaxyproject.org/news/2024-09-16-by-covid-eol/

Galaxy Europe and BY-COVID

In autumn 2021 the EU-funded BY-COVID project was launched to support the response to COVID-19 and our preparedness for future infectious disease outbreaks. Over the past 3 years, the SARS-CoV-2 data analysis efforts of the Galaxy Europe Team have been carried out under the umbrella of BY-COVID with remarkable results.

Among other things, we have:

1. built an automated, scalable SARS-CoV-2 genome surveillance system around Galaxy, which has become a showcase project within the Infectious Diseases Toolkit (IDTk) developed under BY-COVID, and have used it to analyze nearly 500,000 public SARS-CoV-2 sequencing datasets.
2. collaborated with researchers from the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), South Africa, and international colleagues on a first characterization of the omicron variant of concern when it was first observed in late 2021. Read the original blog post and the resulting publication for more.
3. participated in the NIH-led ACTIV TRACE initiative, under which we helped improve and standardize SARS-CoV-2 genome sequencing pipelines of government agencies and industry. Read the publication.
4. extended our analysis support to additional viruses beyond SARS-CoV-2 and have created solutions for influenza and pox virus sequencing data analysis.
5. offered SARS-CoV-2/One Health/Pathogen data analysis tracks as part of the Global Galaxy Training days in 2022 and 2023, and the 2024 Galaxy Training Academy in October will feature a dedicated BY-COVID track.

Looking ahead

BeYond-COVID will reach the end of its funding period in October, but keeping with the project's full name, members of the Galaxy Project and the Galaxy Europe Team will continue their efforts to support high-quality viral pathogen data analysis on the Galaxy platform through the development of tools, workflows, training material and through maintenance of data resources.

To make it easier for you to discover what is available and keep up with future developments, we have set up the subdomain https://virology.usegalaxy.eu earlier this year, which we hope you will find useful. See you there and thanks for using Galaxy!

linkedin-galaxyproject

📝 New blog post Released!
https://galaxyproject.org/news/2024-09-16-by-covid-eol/

Galaxy Europe and BY-COVID (1/3)

In autumn 2021 the EU-funded BY-COVID project: https://by-covid.org/ was launched to support the response to COVID-19 and our preparedness for future infectious disease outbreaks. Over the past 3 years, the SARS-CoV-2 data analysis efforts of the Galaxy Europe Team have been carried out under the umbrella of BY-COVID with remarkable results.

Among other things, we have:

1. built an automated, scalable SARS-CoV-2 genome surveillance system around Galaxy, which has become a showcase: https://www.infectious-diseases-toolkit.org/showcase/covid19-galaxy project within the Infectious Diseases Toolkit (IDTk): https://www.infectious-diseases-toolkit.org/ developed under BY-COVID, and have used it to analyze nearly 500,000 public SARS-CoV-2 sequencing datasets.
2. collaborated with researchers from the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), South Africa, and international colleagues on a first characterization of the omicron variant of concern when it was first observed in late 2021. Read the original blog post: https://galaxyproject.org/news/2021-11-29-omicron-and-galaxy/ and the resulting publication: https://doi.org/10.1093/molbev/msac061 for more.
3. participated in the NIH-led ACTIV TRACE: https://www.nih.gov/research-training/medical-research-initiatives/activ/tracking-resistance-coronavirus-evolution-trace initiative, under which we helped improve and standardize SARS-CoV-2 genome sequencing pipelines of government agencies and industry. Read the publication: https://doi.org/10.3390/v16030430.
4. extended our analysis support to additional viruses beyond SARS-CoV-2 and have created solutions for influenza: https://usegalaxy.eu/published/page?id=a04ab8d6ecb698fa and pox virus: https://usegalaxy.eu/published/page?id=9172077f52d9d49f sequencing data analysis.
5. offered SARS-CoV-2/One Health/Pathogen data analysis tracks as part of the Global Galaxy Training days in 2022: https://gallantries.github.io/video-library/events/smorgasbord2/tapas.html and 2023: https://gallantries.github.io/video-library/events/smorgasbord3/, and the 2024 Galaxy Training Academy: https://training.galaxyproject.org/training-material/events/galaxy-academy-2024.html in October will feature a dedicated BY-COVID track.

: https://training.galaxyproject.org/training-material/events/galaxy-academy-2024.html

Looking ahead

: https://virology.usegalaxy.eu

BeYond-COVID will reach the end of its funding period in October, but keeping with the project's full name, members of the Galaxy Project and the Galaxy Europe Team will continue their efforts to support high-quality viral pathogen data analysis on the Galaxy platform through the development of tools, workflows, training material and through maintenance of data resources.

To make it easier for you to discover what is available and keep up with future developments, we have set up the subdomain https://virology.usegalaxy.eu earlier this year, which we hope you will find useful. See you there (2/3)

and thanks for using Galaxy!

#UseGalaxy #GalaxyProject #UniFreiburg #EOSC #EuroScienceGateway (3/3)

[github-actions]

👋 Hello! I'm your friendly social media assistant. Below are the previews of this post:
posts/feed_bot/galaxy_europe/2024-09-16-by-covid-eol-group2.md

bluesky-galaxyproject

📝 New blog post Released!
https://galaxyproject.org/news/2024-09-16-by-covid-eol/

Galaxy Europe and BY-COVID (1/12)

In autumn 2021 the EU-funded BY-COVID project: https://by-covid.org/ was launched to support the response to COVID-19 and our preparedness for future infectious disease outbreaks. Over the past 3 years, the SARS-CoV-2 data analysis efforts of the Galaxy Europe Team have been carried out (2/12)

under the umbrella of BY-COVID with remarkable results.

Among other things, we have:

1. built an automated, scalable SARS-CoV-2 genome surveillance system around Galaxy, which has become a showcase: https://www.infectious-diseases-toolkit.org/showcase/covid19-galaxy project within the (3/12)

Infectious Diseases Toolkit (IDTk): https://www.infectious-diseases-toolkit.org/ developed under BY-COVID, and have used it to analyze nearly 500,000 public SARS-CoV-2 sequencing datasets.
2. collaborated with researchers from the KwaZulu-Natal Research Innovation and Sequencing Platform (4/12)

(KRISP), South Africa, and international colleagues on a first characterization of the omicron variant of concern when it was first observed in late 2021. Read the original blog post: https://galaxyproject.org/news/2021-11-29-omicron-and-galaxy/ and the resulting publication: (5/12)

https://doi.org/10.1093/molbev/msac061 for more.
3. participated in the NIH-led ACTIV TRACE: https://www.nih.gov/research-training/medical-research-initiatives/activ/tracking-resistance-coronavirus-evolution-trace initiative, under which we helped improve and standardize SARS-CoV-2 genome (6/12)

sequencing pipelines of government agencies and industry. Read the publication: https://doi.org/10.3390/v16030430.
4. extended our analysis support to additional viruses beyond SARS-CoV-2 and have created solutions for influenza: https://usegalaxy.eu/published/page?id=a04ab8d6ecb698fa and (7/12)

pox virus: https://usegalaxy.eu/published/page?id=9172077f52d9d49f sequencing data analysis.
5. offered SARS-CoV-2/One Health/Pathogen data analysis tracks as part of the Global Galaxy Training days in 2022: https://gallantries.github.io/video-library/events/smorgasbord2/tapas.html and 2023: (8/12)

https://gallantries.github.io/video-library/events/smorgasbord3/, and the 2024 Galaxy Training Academy: https://training.galaxyproject.org/training-material/events/galaxy-academy-2024.html in October will feature a dedicated BY-COVID track.

: (9/12)

https://training.galaxyproject.org/training-material/events/galaxy-academy-2024.html

Looking ahead

: https://virology.usegalaxy.eu

BeYond-COVID will reach the end of its funding period in October, but keeping with the project's full name, members of the Galaxy Project and the Galaxy (10/12)

Europe Team will continue their efforts to support high-quality viral pathogen data analysis on the Galaxy platform through the development of tools, workflows, training material and through maintenance of data resources.

To make it easier for you to discover what is available and keep up (11/12)

with future developments, we have set up the subdomain https://virology.usegalaxy.eu earlier this year, which we hope you will find useful. See you there and thanks for using Galaxy!

@galaxyproject.bsky.social
#UseGalaxy #GalaxyProject #UniFreiburg #EOSC #EuroScienceGateway (12/12)

[wm75]

There's an open alternate version already, from which I'll link to the news item.